Sanofi CDR (CAD Hedged) (SNY:TSX) closed at $19.16 on October 23, 2026, down 1.39% on the day. The stock trades 15.1% below its 52-week high of $22.57 and 5.7% above its 52-week low of $18.13. Over the past year, it lost 15.1%. Sanofi CDR (CAD Hedged) is part of the Health Care sector.
In 230 trading sessions since November 24, 2025, SNY closed higher on 76 days (33%). Its best day was March 30, 2026 (+4.51%) and its worst was July 30, 2026 (-10.76%). The stock moved 10% or more in a single session 1 time.
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Find more stocks like SNY with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.